Detailed Information on Publication Record
2021
Healing and Angiogenic Properties of Collagen/Chitosan Scaffolds Enriched with Hyperstable FGF2-STAB(R) Protein: In Vitro, Ex Ovo and In Vivo Comprehensive Evaluation
VOJTOVA, Lucy, Veronika PAVLINAKOVA, Johana MUCHOVA, Katarina KACVINSKA, Jana BRTNIKOVA et. al.Basic information
Original name
Healing and Angiogenic Properties of Collagen/Chitosan Scaffolds Enriched with Hyperstable FGF2-STAB(R) Protein: In Vitro, Ex Ovo and In Vivo Comprehensive Evaluation
Authors
VOJTOVA, Lucy (203 Czech Republic), Veronika PAVLINAKOVA (203 Czech Republic, guarantor), Johana MUCHOVA (203 Czech Republic), Katarina KACVINSKA, Jana BRTNIKOVA (203 Czech Republic), Martin KNOZ (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Martin FALDYNA (203 Czech Republic), Eduard GOPFERT (203 Czech Republic), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Zdeněk PAVLOVSKÝ (203 Czech Republic, belonging to the institution), Monika VICENOVA (203 Czech Republic), Veronika HEFKA BLAHNOVA (203 Czech Republic), Vanessa HEARNDEN and Eva FILOVA (203 Czech Republic)
Edition
BIOMEDICINES, BASEL, MDPI, 2021, 2227-9059
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.757
RIV identification code
RIV/00216224:14110/21:00121944
Organization unit
Faculty of Medicine
UT WoS
000665273200001
Keywords in English
collagen; chitosan; scaffold; FGF2; skin regeneration; tissue engineering
Tags
International impact, Reviewed
Změněno: 19/7/2021 09:37, Mgr. Tereza Miškechová
Abstract
V originále
Wound healing is a process regulated by a complex interaction of multiple growth factors including fibroblast growth factor 2 (FGF2). Although FGF2 appears in several tissue engineered studies, its applications are limited due to its low stability both in vitro and in vivo. Here, this shortcoming is overcome by a unique nine-point mutant of the low molecular weight isoform FGF2 retaining full biological activity even after twenty days at 37 degrees C. Crosslinked freeze-dried 3D porous collagen/chitosan scaffolds enriched with this hyper stable recombinant human protein named FGF2-STAB(R) were tested for in vitro biocompatibility and cytotoxicity using murine 3T3-A31 fibroblasts, for angiogenic potential using an ex ovo chick chorioallantoic membrane assay and for wound healing in vivo with 3-month old white New Zealand rabbits. Metabolic activity assays indicated the positive effect of FGF2-STAB(R) already at very low concentrations (0.01 mu g/mL). The angiogenic properties examined ex ovo showed enhanced vascularization of the tested scaffolds. Histological evaluation and gene expression analysis by RT-qPCR proved newly formed granulation tissue at the place of a previous skin defect without significant inflammation infiltration in vivo. This work highlights the safety and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB(R) protein. Moreover, these sponges could be used as scaffolds for growing cells for dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration.